LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

COVID‐19 in a melanoma patient under treatment with checkpoint‐inhibition

Photo by atikahakhtar from unsplash

Abstract SARS‐CoV‐2 poses new challenges in all aspects of healthcare. Patients with preexisting cardio‐vascular conditions are at higher risk of developing severe symptoms and worse outcome. Data also suggest that… Click to show full abstract

Abstract SARS‐CoV‐2 poses new challenges in all aspects of healthcare. Patients with preexisting cardio‐vascular conditions are at higher risk of developing severe symptoms and worse outcome. Data also suggest that cancer patients are particularly vulnerable, but differences between tumor entities and cancer treatments may exist. Little is known how cancer treatment engaging immune checkpoints affects the course of COVID‐19.

Keywords: treatment checkpoint; treatment; checkpoint inhibition; patient treatment; melanoma patient; covid melanoma

Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.